Monoclonal Antibody to Domain I of β2-glycoprotein I Prevents the Thrombotic Diathesis Associated With the Antiphospholipid Syndrome

被引：0
|
作者：
Lanier, Lane [1 ]
Ulrich, Victoria [1 ]
Tarango, Cristina [1 ]
Yuhanna, Ivan [1 ]
Morrell, Craig N. [2 ]
Shen, Yu-Min [1 ]
Shaul, Philip W. [1 ]
Mineo, Chieko [1 ]
机构：
[1] UT SW Med Ctr Dallas, Dallas, TX USA
[2] Univ Rochester, Aab Cardiovasc Rsch Inst, West Henrietta, NY USA
来源：
CIRCULATION | 2013年 / 128卷 / 22期
关键词：
Thrombosis; Endothelial function; Monoclonal antibodies; Immune system;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
12956
引用
收藏
页数：1
相关论文
共 50 条
  • [41] In vivo inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of β2-glycoprotein I: proof of concept
    Ioannou, Y.
    Romay-Penabad, Z.
    Pericleous, C.
    Giles, I.
    Papalardo, E.
    Vargas, G.
    Shilagard, T.
    Latchman, D. S.
    Isenberg, D. A.
    Rahman, A.
    Pierangeli, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (05) : 833 - 842
  • [42] Immune responses against domain I of β2-glycoprotein I are driven by conformational changes: Domain I of β2-glycoprotein I harbors a cryptic immunogenic epitope
    de Laat, Bas
    van Berkel, Miranda
    Urbanus, Rolf T.
    Siregar, Berdien
    de Groot, Philip G.
    Gebbink, Martijn F.
    Maas, Coen
    ARTHRITIS AND RHEUMATISM, 2011, 63 (12): : 3960 - 3968
  • [43] A Human Monoclonal Antibody Against Domain I Of β2-Glycoprotein I prevents Clotting and Fetal Loss Induced By Polyclonal Anti-Phospholipid Antibodies In Animal Models.
    Agostinis, Chiara
    Durigutto, Paolo
    Sblattero, Daniele
    Borghi, Maria Orietta
    Grossi, Claudia
    Bulla, Roberta
    Macor, Paolo
    Meroni, Pier Luigi
    Tedesco, Francesco
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S245 - S245
  • [44] Heterogeneous recognition of beta 2-glycoprotein I by antibodies from antiphospholipid syndrome patients
    Guerin, J
    Sim, R
    Yu, BB
    Ferluga, J
    Feighery, C
    Jackson, J
    THROMBOSIS AND HAEMOSTASIS, 2000, 84 (03) : 374 - 380
  • [45] Anti-beta 2-glycoprotein I antibodies: A useful marker for the antiphospholipid syndrome
    Teixido, M
    Font, J
    Reverter, JC
    Cervera, R
    Tassies, D
    Ingelmo, M
    Escolar, G
    Ordinas, A
    BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (01): : 113 - 116
  • [46] High avidity anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome
    Cucnik, S
    Kverder, T
    Krizaj, I
    Roaman, B
    Bozic, B
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (11) : 1478 - 1482
  • [47] Correlation between β2-glycoprotein I valine/leucine247 polymorphism and anti-β2-glycoprotein I antibodies in patients with primary antiphospholipid syndrome
    Atsumi, T
    Tsutsumi, A
    Amengual, O
    Khamashta, MA
    Hughes, GRV
    Miyoshi, Y
    Ichikawa, K
    Koike, T
    RHEUMATOLOGY, 1999, 38 (08) : 721 - 723
  • [48] Evaluating the conformation of recombinant domain I of β2-glycoprotein I and its interaction with human monoclonal antibodies
    Pericleous, Charis
    Miles, Jennifer
    Esposito, Diego
    Garza-Garcia, Acely
    Driscoll, Paul C.
    Lambrianides, Anastasia
    Latchman, David
    Isenberg, David
    Rahman, Anisur
    Loannou, Yiannis
    Giles, Ian
    MOLECULAR IMMUNOLOGY, 2011, 49 (1-2) : 56 - 63
  • [49] Antibodies to β2-glycoprotein I, prothrombin and antithrombin III as markers of the antiphospholipid syndrome severity
    J Zabek
    S Luft
    T Reshetniak
    Z Alekberowa
    B Wojciechowska
    W Karlik
    V Nasonowa
    Arthritis Research & Therapy, 3
  • [50] Anti-β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome
    Galli, M
    Luciani, D
    Bertolini, G
    Barbui, T
    BLOOD, 2003, 102 (08) : 2717 - 2723
12345